Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MARX Biotech CoROCO:7731 -2.18%8 PS Ratio is 4.05 as of Jul. 25, 2026, which is 22% below its 10-year median of 5.19. GuruFocus rates ROCO:7731 with a GF Score™ of 8/100. The stock has 4 warning signs investors should review. Among 659 Healthcare Providers & Services companies, MARX Biotech Co ranks worse than 78.45% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, MARX Biotech Co's share price is NT$4.93.
MARX Biotech Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$1.22. Hence, MARX Biotech Co's PS Ratio for today is 4.05.
The historical rank and industry rank for MARX Biotech Co's PS Ratio or its related term are showing as below:
ROCO:7731'
s PS Ratio Range Over the Past 10 Years
Min: 3.23 Med: 5.19 Max: 15.34
Current: 4.05
During the past 6 years, MARX Biotech Co's highest PS Ratio was 15.34. The lowest was 3.23. And the median was 5.19.
ROCO:7731's PS Ratio is ranked worse than 78.45% of 659
companies
in the Healthcare Providers & Services industry
Industry Median: 1.45
vs ROCO:7731: 4.05
During the past 12 months, the average Revenue per Share Growth Rate of MARX Biotech Co was -1.80% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 56.60% per year.
During the past 6 years, MARX Biotech Co's highest 3-Year average Revenue per Share Growth Rate was 56.60% per year. The lowest was 52.00% per year. And the median was 54.30% per year.
Back to Basics: PS Ratio
MARX Biotech Co (ROCO:7731) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
MARX Biotech Co PS Ratio Related Terms
MARX Biotech Co PS Ratio Historical Data
* Premium members only.
The historical data trend for MARX Biotech Co's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, MARX Biotech Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MARX Biotech Co PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MARX Biotech Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where MARX Biotech Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
MARX Biotech Co's Share Price of today is NT$4.93.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MARX Biotech Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$1.22.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
MARX Biotech Co (ROCO:7731) has a PS Ratio of 4.05 as of Jul. 25, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on MARX Biotech Co and its competitors. This is 22% below median its historical median of 5.19. Over the past decade, MARX Biotech Co's PS Ratio has ranged from 3.23 to 15.34. According to the industry distribution chart, MARX Biotech Co ranks #517 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 78.5%.
Is MARX Biotech Co's PS Ratio too high?
MARX Biotech Co's current PS Ratio of 4.05 is 22% below median its 10-year median of 5.19. Over the past 10 years, this metric has ranged from a low of 3.23 to a high of 15.34. The Healthcare Providers & Services industry median PS Ratio is 1.45. MARX Biotech Co's value of 4.05 is 179.3% above this industry median. Based on the distribution chart, MARX Biotech Co ranks #517 out of 659 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, MARX Biotech Co has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does MARX Biotech Co's PS Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, MARX Biotech Co ranks #517 out of 659 companies for PS Ratio. This places MARX Biotech Co in the lower half of its industry. The industry median PS Ratio is 1.45. MARX Biotech Co's value of 4.05 is 179.3% above this benchmark. Historically, MARX Biotech Co's own PS Ratio has ranged from 3.23 to 15.34 over the past decade. While the company's 10-year median is 5.19 vs. the industry median of 1.45, MARX Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.45, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MARX Biotech Co's current PS Ratio of 4.05 is 179.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on MARX Biotech Co and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MARX Biotech Co's current PS Ratio is 4.05, which is 22% below median its own 10-year median of 5.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MARX Biotech Co stock overvalued right now?
MARX Biotech Co (ROCO:7731) has a current PS Ratio of 4.05. The current PS Ratio is 4.05, which is 22% below median its 10-year median of 5.19 and 179.3% above the Healthcare Providers & Services industry median of 1.45. MARX Biotech Co's overall GF Score™ is 8/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For MARX Biotech Co (ROCO:7731), the current PS Ratio is 4.05 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MARX Biotech Co Ltd is a retail company which has developed an O2O and OMO full-channel layout in the online Internet platform and cosmeceutical retail market, and has successfully established itself in the market and Build trust and operational growth on the channel side. It has has established more than three thousand large and small cosmeceutical pharmacies in Taiwan, including: Dashu Pharmacy, Dingding Pharmacy, Cosmed, Watsons, Spring Pharmacy, New Gaoqiao Pharmacy, Anlier Pharmacies, etc.
8GF Score
Get the complete analysis for ROCO:7731
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7731 has been successfully added to your 
